ImmunoPrecise Antibodies Ltd. (NASDAQ:IPA) Q1 2024 Earnings Call Transcript September 14, 2023
ImmunoPrecise Antibodies Ltd. misses on earnings expectations. Reported EPS is $0.11 EPS, expectations were $0.17.
Operator: Good morning, ladies and gentlemen. Thank you for joining us today for IPA’s Earnings Call covering the First Quarter of Fiscal Year 2024. I am Julianne, and I have the privilege of hosting this call. Before we commence, I would like to draw your attention to the fact that...
